Law and regulations in biology - towards user generated solutions
On May 18, 2017, the Copenhagen Bioscience Lecture, featuring Professor Timo Minssen, Center for Information and Innovation Law and Researcher Peter Gottschalk, will identify actual and potential clashes between standardization efforts and IPRs and analyze how such clashes could be adressed both within the IP framework and through ”user-generated solutions.
The Novo Nordisk Foundation Cluster Lectures are a series of open lectures for all researchers and other interested in and around the Copenhagen area. Every 4 weeks, on a Thursday evening, you are invited for lectures on themes with a general interest for the Novo Nordisk Foundation Research Centers. Often there will be a cross-disciplinary focus.
PROGRAMME
15:45 | Welcome and registration (coffee/tea, fruit, water available) |
16:00 | Talk by Timo Minssen on 'Openness, Standardization & Intellectual Property Rights in Synthetic Biology - Towards innovative user-generated solutions' |
16:45 | Talk by Peter Gottschalk on 'Access to genetic resources for research purposes' |
17:30 | Networking with a drink and a snack |
18:30 | Thank you for a splendid end of day! |
ABSTRACT OF TALK BY TIMO MINSSEN
This lecture discusses the complex interface between standardization, IPRs and open innovation in Synthetic Biology and Systems Biology (jointly referred to as SB). This encompasses the consideration of pressing questions of innovation policy, such as whether the technological plurality of SB is compatible with the existing legislation, policies, institutional and governance frameworks for standardization and IPRs. In particular, this lecture will identify actual and potential clashes between standardization efforts and IPRs and analyze how such clashes could be adressed both within the IP framework and through ”user-generated solutions”.
ABSTRACT OF TALK BY PETER GOTTSCHALK
Access to genetic resources is linked to how states exercise sovereign rights over their resources. In the Nagoya Protocol negotiations, access was a main negotiation issue and concerns were raised that more stringent access rules could stifle research. In addition to general access provisions, Article 8 of the Protocol regulates so called ‘Special Considerations’, including non-commercial research. In the EU, a Regulation on implementation of the Nagoya Protocol governs the access issue through a ‘due diligence’ concept. This lecture describes the issue of access to genetic resources for research purposes and discusses how access is governed in the Nagoya Protocol as well as in the EU Regulation on implementation.
TIME AND LOCATION
18 May 2017, 16:00-18:30
Novo Nordisk Foundation
Tuborg Havnevej 19
DK-2900 Hellerup
REGISTRATION
Registration is free of charge, but mandatory via the event's program website on Eventbrite. Please also remember to unregister in case of cancellation.
FURTHER INFORMATION
For further information about the event please contact Sophie Labrosse at sfeb@novo.dk or go to the Novo Nordisk Foundation website